EUREKA THERAPEUTICS, INC.

Profile

Company Names

EUREKA THERAPEUTICS, INC.
EUREKA THERAPEUTICS INC

Addresses

5858 HORTON ST STE 170, EMERYVILLE, CA 94608

5858 HORTON ST STE 370, EMERYVILLE, CA 94608

5858 HORTON ST STE 362, EMERYVILLE, CA 94608

Phone Numbers

(510) 654-7045

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CALIFORNIA

Total Amount Raised:

$112,572,831.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-12-16 
$45,000,000.00 
$45,000,000.00 
$0.00 
Equity 
3
2018-06-04 
$20,000,000.00 
$20,000,000.00 
$0.00 
 
2
2016-12-13 
$26,572,831.00 
$60,000,000.00 
$33,427,169.00 
Equity 
1
2014-08-20 
$21,000,000.00 
$21,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
D. 
CANNON 
DIRECTOR
VIVIEN 
 
CHAN 
EXECUTIVE OFFICER
SANDY 
 
CHAU 
DIRECTOR
WAI-YAN "SANDY" 
 
CHAU 
DIRECTOR
CHIH-KAI "C.K." 
 
CHENG 
DIRECTOR
QIUSHI 
 
FU 
DIRECTOR
HSING 
 
KUNG 
DIRECTOR
CHRISTOPHER 
 
LEHMAN 
EXECUTIVE OFFICER
BIJAN 
 
NEJADNIK 
EXECUTIVE OFFICER
JACQUELINE 
S. 
NORTHCUT 
DIRECTOR
MARVIN 
T. 
SAMSON 
DIRECTOR
VICTOR 
 
SHUM 
EXECUTIVE OFFICER
WILIAM 
S. 
SOLARI III 
DIRECTOR
WILLIAM 
S. 
SOLARI III 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-12-16 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2018-06-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#